Navigation
banner

Infectious Diseases Summit 2017

2018-04-192017-06-132017-05-13
Register 3 for the price of 2 with the coupon code rcdvb!


  Thursday – July 13, 2017
7:00Continental Breakfast & Registration
7:50Welcome & Opening Remarks
8:00Plenary: Responding to Emerging Infectious Diseases on the Global Stage
10:25Morning Networking Break
 Three Parallel Conferences – click the conference title for a detailed agenda
  Antiviral Drugs Research & Development Vaccines Research & Development Anti-Infectives Partnering & Deal-Making
10:55 Session:
Respiratory Viral Infections:
Current Landscape and Emerging Drugs
Session:
Vaccines for Infectious Diseases-
Old & New Challenges
Session:
Non-Traditional Approaches and
Technologies in Anti-Infectives
12:35Lunch on Your Own
2:15 Session:
Blood Borne Pathogens:
New Frontiers in Research and
Drug Development
Session:
Next-Generation
Vaccine Technologies

Session:
Non-Traditional Approaches and
Technologies in Anti-Infectives (cont.)

Session:
Economic Drivers Moving Drug Development Forward

3:55Afternoon Networking Break
4:25 Session:
Blood Borne Pathogens:
New Frontiers in Research and
Drug Development (cont.)
Session:
Next-Generation
Vaccine Technologies (cont.)
Session:
Regulatory Considerations
for Drug Development

Panel Discussion:
Funding & Partnering with US Government Agencies

5:15Evening Reception & Poster Session
 End of Day 1
  Friday – July 14, 2017
 Three Parallel Conferences – click the conference title for a detailed agenda
  Antiviral Drugs Research & Development Vaccines Research & Development Anti-Infectives Partnering & Deal-Making
7:15Breakfast with Mentors
8:30 Session:
Challenges in Clinical Study Design
and Considerations

Panel Discussion:
New Approaches
to Antiviral Development

Session:
Enhancing Immunity at Both Ends
of the Age Spectrum

Panel Discussion:
Clinical Trial Design During Epidemics

Panel Discussion:
Pushing and Pulling – What Incentives Help Spark Innovation in Antibiotic Drug Discovery and Development?

Panel Discussion:
Pricing and P&T Committee’s Role in Determining Novel Antibiotic Usage

10:10Morning Networking Break
10:40

Roundtable Discussions:

The Past, Present, and Future of Hepatitis Infection

The Race for an Antiviral Against Zika

Flu Pandemic

Roundtable Discussions:

Technologies and Strategies in Influenza Vaccines

Optimization of Vaccine Delivery

Vaccine Development Efforts for Emerging Infectious Diseases

Roundtable Discussions:

Workforce Attrition in Antibiotic Development industry

Pharmacokinetics-Pharmacodynamics (PK/PD) in Developing Anti-Infectives

12:00Lunch Provided by GTCbio
1:00General Session: Public/Private Partnerships in Support of Global Health
2:40Conferences Concludes
*All times are approximate and subject to change without notice